Cover image for Quality of care for women : a review of selected clinical conditions and quality indicators
Title:
Quality of care for women : a review of selected clinical conditions and quality indicators
Author:
McGlynn, Elizabeth A.
Publication Information:
Santa Monica, CA : Rand, 2000.
Physical Description:
xiv, 431 pages ; 28 cm.
General Note:
"MR-1284-HCFA" -- back cover.

"Supported by the Health Care Financing Administration, U.S. Department of Health and Human Services."
Language:
English
Contents:
Preface -- Tables -- Acknowledgements -- Introduction -- 1. Acne -- 2. Alcohol dependence -- 3. Allergic rhinitis -- 4. Asthma -- 5. Breast mass -- 6. Cesarean delivery -- 7. Cigarette use counseling -- 8. Depression -- 9. Diabetes mellitus -- 10. Family planning/contraception -- 11. Headache -- 12. Hypertension -- 13. Low back pain (acute) -- 14. Prenatal care -- 15. Preterm labor, cortisteroids for fetal maturation -- 16. Preventive care -- 17. Upper respiratory infections -- 18. Urinary tract infection -- 19. Vaginitis and sexually transmitted diseases, diagnosis and treatment -- Appendix A: Definitions for indicator tables -- Appendix B: Panel ratings sheets by condition -- Appendix C: Crosswalk table of original and final indicators.
Reading Level:
1410 Lexile.
Added Author:
ISBN:
9780833029232
Format :
Book

Available:*

Library
Call Number
Material Type
Home Location
Status
Central Library RA399.A3 Q346 2000 Adult Non-Fiction Central Closed Stacks-Oversize
Searching...

On Order

Summary

Summary

This report is one of five volumes providing detailed information on the QA Tools, RAND's comprehensive, clinically based system for assessing quality of care for children and adults. The QA Tools indicators encompass screening, diagnosis, treatment, and follow-up in 46 clinical areas and cover a variety of modes of providing care, including history, physical examination, laboratory study, medication, and other interventions and contacts.Development of each indicator was based on the ratings of a panel of experts in the relevant fields and on a focused review of the scientific literature, which is clearly documented for each clinical condition. This volume focuses on indicators for care of women. Each chapter summarizes the results of the literature review for a particular condition, provides RAND staff's recommended indicators based on that review, and lists the cited studies. In addition, this work details the process by which the expert panelevaluated the indicators and the final disposition of each indicator. Clinical conditions covered in this volume are: Acne, alcohol dependence, allergic rhinitis, asthma, breast mass, cesarean delivery, cigarette use counseling, depression, diabetes mellitus, family planning/contraception, headache, hypertension, acute low back pain, prenatal care, preterm labor-cortisosteroids for fetal maturation, preventive care, upper respiratoryinfections, urinary tract infection, vaginitis and sexually transmitted diseases. Other RAND Health titles on the QA Tools system focus on indicators for general medicine, oncology and HIV, cardiopulmonary conditions, and care of children and adolescents.


Table of Contents

Prefacep. iii
Tablesp. xi
Acknowledgmentsp. xiii
Introductionp. 1
Advantages Of The QA Tools Systemp. 1
Selecting Clinical Areas For The QA Toolsp. 3
Selecting Quality Indicatorsp. 6
Literature Reviewp. 6
Types of Indicatorsp. 7
The Expert Panel Processp. 8
Developing Quality Indicators For Womenp. 14
Selecting Clinical Areasp. 15
Conducting Literature Reviewsp. 17
Developing Indicatorsp. 18
Selecting Panel Participantsp. 19
Selecting the Final Indicatorsp. 20
Analyzing The Final Indicatorsp. 22
Conclusionp. 24
Organization Of This Documentp. 25
Referencesp. 26
1. Acnep. 29
Importancep. 29
Efficacy and/or Effectiveness of Interventionsp. 29
Screeningp. 29
Diagnosisp. 30
Treatmentp. 31
Follow-upp. 33
Recommended Quality Indicators For Acnep. 34
References - Acnep. 36
2. Alcohol Dependencep. 37
Importancep. 37
Efficacy and/or Effectiveness of Interventionsp. 38
Screeningp. 38
Initial Evaluationp. 39
Treatmentp. 39
Follow-upp. 41
Recommended Quality Indicators For Alcohol Dependencep. 42
References - Alcohol Dependencep. 44
3. Allergic Rhinitisp. 47
Importancep. 47
Efficacy/Effectiveness of Interventionsp. 47
Diagnosisp. 47
Treatmentp. 48
Recommended Quality Indicators For Allergic Rhinitisp. 50
References - Allergic Rhinitisp. 51
4. Asthmap. 53
Importancep. 53
Diagnosisp. 54
Efficacy and/or Effectiveness of Interventionsp. 56
Patient Educationp. 56
Pharmacologic Therapyp. 57
Diagnosis and Treatment of Allergic Asthmap. 58
General Management Principlesp. 59
Chronic Mild Asthmap. 59
Chronic Moderate Asthmap. 59
Chronic Severe Asthmap. 60
Other Management Measuresp. 60
Care of an Acute Asthma Exacerbationp. 60
Care of Patients Hospitalized for Asthmap. 62
Recommended Quality Indicators For Asthmap. 64
References - Adult Asthmap. 69
5. Breast Massp. 71
Importancep. 71
Efficacy And/Or Effectiveness Of Interventionsp. 71
Recommended Quality Indicators For Breast Massp. 74
References - Breast Massp. 75
6. Cesarean Deliveryp. 77
Importancep. 78
Prior Cesarean Deliveryp. 79
Importancep. 79
Efficacy and/or Effectiveness of Interventionsp. 80
Treatment with Repeat Cesarean vs. Trial of Laborp. 80
Recommended Quality Indicators For Prior Cesarean Deliveryp. 83
Cesarean Delivery for Failure to Progress in Laborp. 85
Importancep. 85
Efficacy and/or Effectiveness of Interventionsp. 85
Diagnosisp. 85
Treatmentp. 87
Recommended Quality Indicators For Cesarean Delivery For Failure To Progress In Laborp. 89
Fetal Distress/Non-reassuring Fetal Status and Intrapartum Fetal Heart Rate Monitoringp. 91
Importancep. 91
Efficacy and/or Effectiveness of Interventionsp. 91
Diagnosisp. 91
Recommended Quality Indicators For Cesarean Delivery for Fetal Distressp. 94
Prophylactic Antibiotics For Cesarean Deliveryp. 95
Importancep. 95
Efficacy and/or Effectiveness of Interventionsp. 95
Preventionp. 95
Recommended Quality Indicators For Antibiotic Prophylaxis for Cesarean Deliveryp. 98
References - Cesarean Deliveryp. 99
7. Cigarette Use Counselingp. 103
Importancep. 103
Efficacy and/or Effectiveness of Interventionsp. 104
Screening and Initial Evaluationp. 104
Treatment and Preventionp. 104
Follow-upp. 106
Recommended Quality Indicators For Cigarette Use Counselingp. 107
References - Cigarette Use Counselingp. 109
8. Depressionp. 111
Importancep. 111
Efficacy and/or Effectiveness of Interventionsp. 112
Screening/Detectionp. 112
Diagnosisp. 114
Treatmentp. 115
Follow-upp. 117
Recommended Quality Indicators For Depressionp. 119
References - Depressionp. 123
9. Diabetes Mellitusp. 125
Importancep. 125
Efficacy and/or Effectiveness of Interventionsp. 126
Screeningp. 126
Diagnosisp. 126
Treatmentp. 129
Follow-upp. 131
Recommended Quality Indicators For Diabetes Mellitusp. 132
References - Diabetesp. 135
10. Family Planning/Contraceptionp. 139
Importancep. 139
Efficacy of Interventionp. 140
Screening for Risk of Unintended Pregnancyp. 140
Treatmentp. 141
Recommended Quality Indicators For Family Planning/Contraceptionp. 143
References - Family Planning/Contraceptionp. 145
11. Headachep. 147
Importancep. 147
Efficacy and/or Effectiveness of Interventionsp. 147
Diagnosisp. 147
Treatmentp. 149
Follow-up Carep. 150
Recommended Quality Indicators For Headachep. 152
References - Headachep. 154
12. Hypertensionp. 157
Importancep. 157
Efficacy and/or Effectiveness of Interventionsp. 158
Screeningp. 158
Initial Evaluationp. 158
Treatmentp. 160
Follow-upp. 162
Recommended Quality Indicators for Hypertensionp. 163
References - Hypertensionp. 167
13. Low Back Pain (Acute)p. 171
Importancep. 171
Efficacy and/or Effectiveness of Interventionsp. 173
Primary Preventionp. 173
Diagnosisp. 174
Treatmentp. 175
Recommended Quality Indicators For Acute Low Back Painp. 179
References - Low Back Painp. 183
14. Prenatal Carep. 189
Importancep. 190
Efficacy and/or Effectiveness of Interventionsp. 193
Timing and Frequency of Visitsp. 193
Gestational Age Determinationp. 194
Nutrition and Anemiap. 195
Substance Abusep. 198
Infections and Sexually Transmitted Diseasesp. 204
Congenital Fetal Disordersp. 211
Common Pregnancy Complicationsp. 217
Recommended Quality Indicators For Prenatal Carep. 225
References - Prenatal Carep. 236
15. Preterm Labor, Corticosteroids For Fetal Maturationp. 259
Importancep. 259
Efficacy and/or Effectiveness of Interventionsp. 259
Recommended Quality Indicators For Corticosteroids For Fetal Maturation In Laborp. 262
References - Corticosteroids For Fetal Maturation In Laborp. 263
16. Preventive Carep. 265
Immunizationsp. 266
Importancep. 266
Tetanusp. 266
Diphtheriap. 267
Influenzap. 267
Efficacy and/or Effectiveness of Interventionsp. 268
Sexually Transmitted Diseases and HIV Preventionp. 268
Importancep. 269
Efficacy and/or Effectiveness of Interventionsp. 269
Obesity Counselingp. 271
Importancep. 271
Efficacy and/or Effectiveness of Interventionsp. 272
Seat Belt Use Counselingp. 273
Importancep. 273
Efficacy and/or Effectiveness of Interventionsp. 274
Breast Examinationp. 275
Importancep. 275
Efficacy and/or Effectiveness of Interventionsp. 275
Hyperlipidemia Screeningp. 278
Importancep. 278
Efficacy and/or Effectiveness of Interventionsp. 278
Screeningp. 278
Efficacy of Early Treatmentp. 279
Recommendationsp. 280
Hypertension Screeningp. 281
Cervical Cancer Screeningp. 281
Importancep. 281
Effectiveness of Interventionsp. 282
Screeningp. 282
Management of Women with Abnormal Pap Smearsp. 284
Recommended Quality Indicators For Routine Preventive Carep. 286
References - Routine Preventive Carep. 289
17. Upper Respiratory Infectionsp. 295
Importancep. 295
Pharyngitis, Acutep. 296
Efficacy and/or Effectiveness of Interventionsp. 296
Diagnosisp. 296
Treatmentp. 297
Follow-upp. 298
Bronchitis, Acutep. 298
Importancep. 298
Efficacy and/or Effectiveness of Interventionsp. 298
Diagnosisp. 298
Treatmentp. 299
Influenzap. 299
Importancep. 299
Efficacy and/or Effectiveness of Interventionsp. 300
Diagnosisp. 300
Treatmentp. 300
Nasal Congestion and Rhinorrheap. 301
Importancep. 301
Efficacy and/or Effectiveness of Interventionsp. 301
Diagnosis and Treatmentp. 301
Sinusitisp. 302
Importance-Acute and Chronic Sinusitisp. 302
Efficacy and/or Effectiveness of Interventionsp. 303
Acute Sinusitisp. 303
Chronic Sinusitisp. 304
Treatmentp. 304
Recommended Quality Indicators For Upper Respiratory Infectionsp. 306
References - Upper Respiratory Infectionsp. 310
18. Urinary Tract Infectionp. 313
Importancep. 313
Efficacy and/or Effectiveness of Interventionsp. 313
Screeningp. 313
Diagnosisp. 313
Treatmentp. 315
Follow-upp. 316
Recommended Quality Indicators For Urinary Tract Infectionp. 318
References - Urinary Tract Infectionp. 322
19. Vaginitis and Sexually Transmitted Diseases, Diagnosis and Treatmentp. 325
Vulvovaginitisp. 325
Importancep. 325
Efficacy and/or Effectiveness of Interventionsp. 326
Screeningp. 326
Diagnosisp. 326
Treatmentp. 328
Follow-up Carep. 330
Diseases Characterized by Cervicitisp. 330
Importancep. 330
Efficacy and/or Effectiveness of Interventionsp. 331
Screeningp. 331
Diagnosisp. 331
Treatmentp. 331
Follow-up Carep. 333
Pelvic Inflammatory Disease (PID)p. 333
Importancep. 333
Efficacy/Effectiveness of Interventionsp. 333
Diagnosisp. 333
Treatmentp. 334
Follow-up Carep. 336
Diseases Characterized by Genital Ulcersp. 336
Importancep. 336
Efficacy and/or Effectiveness of Interventionsp. 336
Genital Herpes Simplex Infectionp. 336
Chancroidp. 337
Primary and Secondary Syphilisp. 338
Recommended Quality Indicators For Vaginitis And Sexually Transmitted Diseasesp. 340
References - Vaginitis And Sexually Transmitted Diseasesp. 345
Appendix A Definitions for Indicator Tablesp. 347
Appendix B Panel Ratings Sheets By Conditionp. 353
Appendix C Crosswalk Table of Original and Final Indicatorsp. 401

Google Preview